PaxMedica Inc

NASDAQ:PXMD   4:00:00 PM EDT
2.24
-0.52 (-18.84%)
7:59:57 PM EDT: $2.36 +0.12 (+5.36%)
Products

Paxmedica Initiates Clinical Program To Advance Pax-101 Towards FDA Submission

Published: 11/08/2022 15:35 GMT
PaxMedica Inc (PXMD) - Paxmedica Initiates Clinical Program to Advance Pax-101 Towards FDA Submission.
Paxmedica Inc - Final Study Results Are Expected in First Half of 2023.